Dry Eye Syndromes Clinical Trial
Official title:
The Expression Levels of Diadenosine Polyphosphates and Mucin in Mechanical Stress-related Ocular Surface Disorders
Dry eye disease, ocular graft-versus-host disease (GVHD), and superior limbic
keratoconjunctivitis (SLK) are all ocular surface disorders which mostly involve the outer
surface of the eye. Many of the ocular surface disorders may result from or be aggravated by
the mechanical stress from eyelid blinking. Specifically, SLK is an inflammatory ocular
surface disorder characterizing by redundant superior bulbar conjunctiva. Since redundant
superior bulbar conjunctiva can cause a significant mechanical force during eyelid blinking,
we found that conjunctival resection with Tenon's capsule excision is helpful in relieving
the symptoms of SLK patients. Therapeutic contact lens, protecting the ocular surface from
the microtrauma between eyelid and ocular surface, is also an effective treatment for severe
dry eye disease, ocular GVHD, and SLK. Although shearing force/mechanical stress has been
studied in many different tissues and disease entities, the impact of shearing force over
ocular surface is still unclear.
While the importance of mechanical stress in ocular surface disorder has been reported, the
specific molecule involving the pathogenesis is still unknown. Diadenosine polyphosphates are
a family of dinucleotides. They can enhance tear secretion and increase corneal wound healing
rate from previous reports. Shear-stress stimuli was also noted to be able to induce
diadenosine polyphosphates releasing from human corneal epithelium. In addition, mucin, one
of the three components of tear film, has been greatly emphasized in the pathogenesis of dry
eye disease. There are also some reports about the shearing force compensating the mucin
contents in the inflammatory lung/bowel diseases. If diadenosine polyphosphates or mucin
indeed play a role in mechanical stress-related ocular surface disorders, it will be a
promising therapeutic targeting in the future.
Ocular surface disorders are diseases involving the most outer surface of the eyeball - the
transparent layers that forms the front of the eye, including cornea and conjunctiva. One of
the most common ocular surface disorders is dry eye disease (DED) which has a great impact on
patients' quality of life. In addition, ocular graft-versus-host disease (GVHD) and superior
limbic keratoconjunctivitis (SLK) are also ocular surface disorders affecting patients'
quality of life significantly.
1. Great impact of ocular surface disorders on quality of life 1.1. Impact of dry eye
disease Dry eye disease (DED) is a common ocular surface disorder. Vision-related
quality of life in dry eye patients is impaired and is correlated with anxiety and
depression.1 Patients with DED are often evaluated by a symptom scale called ocular
surface disorder index (OSDI). The OSDI is a valid and reliable scale for diagnosis and
measurement of the severity of DED or other ocular surface disorder. It is also a
convenient option for clinical use as a result of its shorter completion time.
1.2. Impact of GVHD GVHD caused by alloreactive donor T cells is an important cause of
nonrelapse mortality and morbidity after allogeneic hematopoietic cell transplantation
(HCT). Ocular GVHD reportedly occurs in more than 50% of allogeneic HCT recipients with
chronic GVHD. It can affect all parts of the eye, but the ocular surface is the most
common level of involvement. Yoshi et al suggested strong correlations of serial changes
in the NIH eye score, the OSDI, and the Lee eye subscale. Given that the OSDI consists
of 12 items instead of the 3 for the Lee eye subscale, they found little basis for
recommending the OSDI to measure change in the activity of ocular GVHD. Therefore, the
Lee eye subscale might be a good choice for determining the impact of ocular GVHD on
quality of life.
1.3. Impact of SLK SLK is an ocular surface disorder characterized by unilateral or
bilateral redundancy of the superior bulbar conjunctiva with inflammation of the
superior tarsal and bulbar conjunctiva. There are many patients suffering by the
symptoms of SLK because of its unclear etiology and no standard treatment. In addition,
SLK is not easy to make a definite diagnosis, the impact of SLK on quality of life could
be underestimated.
2. Mechanical stress from eyelid blinking may be an aggravating or contributing factor of
ocular GVHD and SLK 2.1. The symptoms of ocular GVHD relieved by bandage soft contact
lens (BSCL) application via the isolation from mechanical stress (eyelid blinking) and
ocular surface The standard treatment of ocular GVHD is still not in consensus. Because
of the immune reaction participating in the pathogenesis of ocular GVHD, some topical
immunosuppressants, such as cyclosporine A (CsA) and tacrolimus, are applied on the
patients with ocular GVHD. Allogeneic serum eye drops and autologous plasma rich in
platelet-derived growth factor (PDGF) eye drops were also reported to be effective in
chronic ocular GVHD patients. For medication refractory cases, punctal plugs, scleral
lens, and bandage soft contact lens (BSCL) could be applied as alternative treatments
for ocular GVHD patient. According to previous report, BSCL is a safe and effective
treatment option that improves manifestations of ocular GVHD. BSCL can act as a barrier
to further epithelial disruption and corneal nerve stimulation by the shearing force of
the upper lid during the blink.
2.2. Mechanical stress plays a role in the pathogenesis of SLK Mechanical stimulation
may contribute to the pathogenesis of SLK. We speculated that this kind of physical
trauma not only results in the keratinization of conjunctival epithelium, but also
induced inflammatory cells and mediators, such as mast cells and cytokines,
respectively. Three out of 8 SLK patients benefitted from large diameter contact lens
application. Conjunctival resection with Tenon's capsule excision was also reported as a
beneficial treatment for medication refractory SLK patients.
3. The expression of diadenosine polyphosphates and mucin may alter the clinical
presentation or diagnosis of ocular surface disorders 3.1. Dinucleoside polyphosphates
in ocular surface disorder Diadenosine polyphosphates are a family of dinucleotides,
consisting of two adenosine nucleosides joined by a phosphate chain whose length can
vary from 2 to 7 phosphates. They are released from nerve terminals to the extracellular
milieu where they can exert actions by interacting with purinergic receptors.
Since the levels of diadenosine tetraphosphate (Ap4A) and diadenosine pentaphosphate
(Ap5A) in tears were found to be greater in all dry eye patients, these compounds could
be objective markers to score dry eye. In the forced blink experiments, concentrations
of the diadenosine polyphosphates rose with increasing blink frequency.13 In addition,
topical application of diadenosine tetraphosphate was also noted to be able to stimulate
tear secretion in vivo. Because of the higher levels of Ap4A found in refractive surgery
patients during the first day after the surgery, this dinucleotide release might help in
the wound healing process as well.
3.2. Mucin in ocular surface disorder Mucin plays an important role over the ocular
surface. It converts the hydrophobic corneal surface to a hydrophilic surface by
adhering to the glycocalyx on the corneal microvilli. It also contributes differently to
the protection of the ocular surface against allergens, pathogens, extracellular
molecules, abrasive stress, and drying. MUC1 (mucin 1), 2, 4, 5AC, and 7 are the
subtypes of mucin that can be found over ocular surface, including cornea, conjunctiva,
goblet cell, and lacrimal gland.
Ocular surface pathologies, i.e. dry eye syndrome or allergic conjunctivitis, are
reportedly associated with alteration of expression pattern of mucin components.
Although dryness of the ocular surface is a fundamental situation, local inflammation in
the epithelium plays critical roles in the pathogenesis and symptom in patients with dry
eye syndrome. Mucin deficiency can lead to inflammation in the ocular surface.
Expression of MUC1, MUC2, MUC4, and MUC5AC are significantly lower in conjunctival
epithelium gathered by impression cytology in the patients with dry eye syndrome
compared with that in normal subject.18 Reduction of MUC1 expression in dry eye local
tissue is reportedly most prominent and could be a marker for diagnosis or evaluation of
the disease severity. Topical eye drop of Rebamipide, a drug that is capable of
stimulating of mucin secretion in gastrointestinal tract or conjunctiva, is approved in
Japanese government for use in the treatment of dry eye diseases.
Mucin was also reported as an important factor contributing to some allergic
keratoconjunctivitis. In the patients with atopic keratoconjunctivitis, expression of
goblet cell-specific mucin, MUC5AC mRNA, was reduced and MUC16 mRNA expression was
upregulated in brush cytology specimens. Besides, patients with vernal
keratoconjunctivitis had increased numbers of conjunctival goblet cells from impression
cytology specimen. This phenomenon also altered the levels of mucin over the ocular
surface.
4. Mechanical stress can violate the levels of diadenosine polyphosphates and mucin 4.1.
Diadenosine polyphosphate under mechanical stress It is known that cells under stress
accumulate various dinucleoside polyphosphates, compounds suggested to function as
alarmones. The release of diadenosine polyphosphates to the tears can be caused by shear
stress, such as that corneal epithelial cells release these molecules as a consequence
of the lid contact during the blinking process. Daily wear of rigid gas permeable lenses
also can increase the levels of Ap4A due to mechanical stimulation by blinking of the
corneal epithelium, and this is associated with discomfort.
4.2. Mucin under mechanical stress Gastrointestinal tract and upper airway are the organ
systems filled with mucin as an important protection. MUC1 and MUC4 in the colon and MUC3 in
the duodenum were upregulated in stressed animals. These findings suggest that chronic stress
may affect mucin expression in the gastrointestinal tract. In addition, human bronchial
epithelial cell cultures (HBECCs) are very sensitive to the mechanical stress associated with
handling and pipetting. Mucin secretion at baseline in vivo occurs in a mechanically dynamic
lung environment: goblet cells are exposed continuously to mechanical forces, shear stress
and compressive stress, that may stimulate and/or influence the production and secretion of
mucins.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04425551 -
Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction
|
N/A | |
Not yet recruiting |
NCT06379685 -
Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface.
|
Phase 1 | |
Recruiting |
NCT04701086 -
3 Month Study of Cationorm Pro Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis
|
N/A | |
Active, not recruiting |
NCT03697876 -
Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel
|
Phase 1 | |
Completed |
NCT02910713 -
Evaluation of Dry Eye Symptoms in CAE With Application of Intranasal Neurostimulation
|
N/A | |
Terminated |
NCT02815293 -
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
|
Phase 3 | |
Completed |
NCT04104997 -
A Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of GLH8NDE After Single and Mutiple Ocular Administrations in Healthy Korean and Caucasian Volunteers
|
Phase 1 | |
Recruiting |
NCT02595606 -
0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients
|
Phase 4 | |
Completed |
NCT01711424 -
An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease
|
N/A | |
Completed |
NCT01202747 -
Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction
|
Phase 2/Phase 3 | |
Completed |
NCT01015209 -
Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young Volunteers
|
Phase 1 | |
Completed |
NCT00969280 -
Acupuncture for Dry Eye Syndrome
|
Phase 3 | |
Completed |
NCT00739713 -
Effects of Sea Buckthorn Oil on Dry Eye
|
N/A | |
Completed |
NCT01496482 -
Comparison of Evaporimetry With the Established Methods of Tear Film Measurement
|
N/A | |
Completed |
NCT00756678 -
Efficacy and Acceptability of Two Lubricant Eye Drops
|
Phase 4 | |
Completed |
NCT00349440 -
Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy
|
Phase 4 | |
Completed |
NCT00370747 -
Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
|
Phase 2 | |
Completed |
NCT05162261 -
to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction
|
N/A | |
Completed |
NCT02871440 -
A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye
|
Phase 3 | |
Completed |
NCT05042960 -
Computer Screen Properties Study
|
N/A |